UPF spinoff Integra Therapeutics obtains 4.5 million euros to develop its genetic editing technologyD3veloperSCS_dcexs212023-07-12T15:18:24+00:00
Unidad de Excelencia María de Maeztu”, funded by the MCIN and the AEI (DOI: 10.13039/501100011033). Ref: CEX2018-000792-M
